Delivery Order SPM20003D1666-QV17
Award Date 7/30/08
Potential Completion Date 7/30/08
Potential Value $33K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
West Sacramento, CA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, with a ceiling value of $18,404.70 for Photrexa cross-linking kit 6ml, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. PPV-G GEN V is a DLA-administered pharmaceutical supply contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, for $30,674.50 to supply Photrexa cross-linking kit (6 mL) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations worldwide. DMS...
- The Defense Logistics Agency issued a $5,881.12 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 11, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for VABYSMO 6 MG/0.05 ML syringes. PPV-G GEN V is the Defense Logistics Agency's indefinite delivery contract authorizing firm fixed-price orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, for $15,337.25 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Photrexa Cross-Linking Kit 6ml. PPV-G GEN V is the Defense Logistics Agency's pharmaceutical prime vendor program, structured as a single-award indefinite delivery contract with a $499.9 billion ceiling authorizing firm fixed-price delivery orders for branded and generic...
- The Defense Logistics Agency issued a $15,337.25 delivery order to DMS Pharmaceutical Group Inc. on February 11, 2026, for Photrexa cross-linking kit 6ml under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group Inc....
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, for $1,222.27 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of OMIDRIA 1–0.3% vial 4ML. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. The ceiling value for this delivery order is $1,222.27, with ultimate completion on March 4,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, for YF-VAX 1 dose vials with a ceiling value of $1,259.08 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 10, 2026, for etonogestrel 68 mg with a ceiling value of $24,244.87 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, with a ceiling value of $8,431.61 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, with a ceiling value of $17,922.40 for supply of Prolastin C 1,000 mg/20 ml vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a...